clinical trial Archive — Page 9 of 16

The study could suggest ways to promote the transport of phospholipids and cholesterol out of macrophages, immune system cells that play key roles in all stages of atherosclerosis development.
March 23, 2023

Reminders for clinicians improve prescribing for high cholesterol

A Vanderbilt study found that automated targeted reminders for clinicians helped increase prescribing of high intensity statins for patients with various atherosclerotic cardiovascular disease diagnoses, including coronary or peripheral artery disease and ischemic stroke.

By Paul Govern
March 7, 2023

Nicole Kidman and Keith Urban gift supports breast cancer clinical trials at Vanderbilt-Ingram Cancer Center

Nicole Kidman and Keith Urban have made a generous financial gift to Vanderbilt-Ingram Cancer Center in support of clinical trials for new and better therapies for breast cancer.

By Tom Wilemon
In the bridge-enhanced ACL restoration process, a sponge-like implant creates an environment in which torn ACL fibers can heal.
March 2, 2023

Multisite clinical trial to test new ACL repair procedure

Vanderbilt orthopaedic surgeons are revisiting the method of used to repair torn anterior cruciate ligaments.

By Danny Bonvissuto
February 23, 2023

Trial seeks to expand therapies for biliary cancers

A Vanderbilt clinical trial seeks to optimize the effect of immunotherapies for patients with biliary tract cancers who have already progressed on first-line therapy.

By Tom Wilemon
A study found that aspirin counteracts clotting as effectively as other treatments and is also cheaper.
February 9, 2023

Aspirin’s effectiveness at preventing blood clots studied

A Vanderbilt study found that aspirin is as effective as low molecular weight heparin at preventing hospital-acquired deep venous thromboembolism, or blood clots in the veins, for orthopaedic trauma patients.

By Danny Bonvissuto
Wesley Self, MD, MPH
February 2, 2023

Study of two sepsis interventions finds identical outcomes

Vanderbilt University Medical Center had a leading role in a large national study designed to compare two early interventions in the treatment of patients with sepsis, the body’s severe response to an uncontrolled infection.

By Nancy Humphrey